Abstract
Traditionally, treatment of disease is carried out by small molecules that
target specific cell types. In diseases such as cancer, the treatment is meant
to kill cancer cells, leading to the removal or at least the inhibition of
cancer cell proliferation. In other circumstances, a variety of therapeutic
molecules have been utilized lead the disease cells to perform a specific
function that they normally do not. These include small molecules, peptides,
proteins, antibodies, anti-sense RNAs and ribozymes. In the case of cell
therapy, as the name indicates, treatment is carried out with cells instead of
small molecules. In cell therapy, cells are given to the patient as the
therapeutic delivery system for a specific disease to achieve therapeutic
benefit. The purpose of this TriMark Publications report is to describe the
market segment of the cell therapy market aimed specifically at cancer
therapy. Moreover, a review of cellular agents that are related to the
chemical and cellular constituents of blood or other tissues for cancer care
of the patient is addressed in this study. The two most important areas where
such agents are used are in the hospital and the clinic. Emphasis is on those
companies and products that are actively developing and marketing cell
therapeutic agents and supplies for treating cancer patients.
View Cart
